✨ Your Portfolio is fetched and updated from zerodha.
Pharmaceuticals
Market Cap
₹487 Cr.
P/E
23.72

Key Ratios

Market cap
Market cap
487 Cr
PE
PE
23.72
Prom Holding
Prom Holding
52.68 %
ROE (%)
ROE (%)
25.51
ROCE (%)
ROCE (%)
25.52
Div Yield (%)
Div Yield (%)
-
Sales
Sales
120 Cr
OPM (%)
OPM (%)
0.27 %
Debt to Equity
Debt to Equity
0.83
About
Anlon Healthcare Ltd. manufactures high-purity pharma intermediates and APIs for medicines, nu… Read more
Low
91
52W Range
High
93
  • Anlon Healthcare
  • Kronox Lab Sciences
  • Acutaas Chemicals

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

4 Yes

Positive for this company

3 Neutral

Neutral for this company

2 No

Negative for this company

8 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison
FAQs on Anlon Healthcare Ltd. Business

Anlon Healthcare is a chemical manufacturing company, engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in India and international markets. Its products span across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API. It is also engaged in custom API development, including the preparation and submission of regulatory Drug Master Files (DMFs) for Indian and global markets.

Anlon Healthcare major competitors are Kronox Lab Sciences, Acutaas Chemicals, Supriya Lifescience.
Market Cap of Anlon Healthcare is ₹487 Crs.
While the median market cap of its peers are ₹5,326 Crs.

Anlon Healthcare seems to be less financially stable compared to its competitors.
Altman Z score of Anlon Healthcare is 5.09 and is ranked 4 out of its 4 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material